Giraldo P - Search Results

1

Muscle-tendon weakness contributes to chronic fatigue syndrome in Gaucher's disease.

Roca-Espiau M, Andrade-Campos M, Cebolla JJ, López de Frutos L, Medrano-Engay B, López-Royo MP, Giraldo P. Roca-Espiau M, et al. Among authors: giraldo p. J Orthop Surg Res. 2019 Nov 21;14(1):383. doi: 10.1186/s13018-019-1452-y. J Orthop Surg Res. 2019. PMID: 31752949 Free PMC article.

2

[Neurological manifestations in patients with Gaucher disease and in their relatives].

Giraldo P, Capablo JL, Alfonso P, Latre P, García B, Pocoví M; Grupo Español sobre Enfermedad de Gaucher. Giraldo P, et al. Med Clin (Barc). 2008 Jul 5;131(5):175-9. doi: 10.1157/13124962. Med Clin (Barc). 2008. PMID: 18674488 Spanish.

3

[Safety of use of velaglucerase in 2 patients with type 1 Gaucher's disease].

Latre P, Giraldo P. Latre P, et al. Among authors: giraldo p. Med Clin (Barc). 2011 Sep;137 Suppl 1:39-42. doi: 10.1016/S0025-7753(11)70015-X. Med Clin (Barc). 2011. PMID: 22230124 Spanish.

4

[Therapeutic targets in Gaucher's disease].

Giraldo P, Roca M. Giraldo P, et al. Med Clin (Barc). 2011 Sep;137 Suppl 1:46-9. doi: 10.1016/S0025-7753(11)70017-3. Med Clin (Barc). 2011. PMID: 22230126 Spanish.

5

[Current treatment for Gaucher's disease and new prospects].

Giraldo P, Latre P. Giraldo P, et al. Med Clin (Barc). 2011 Sep;137 Suppl 1:50-4. doi: 10.1016/S0025-7753(11)70018-5. Med Clin (Barc). 2011. PMID: 22230127 Spanish.

6

[Guidelines for type 1 Gaucher's disease].

Giraldo P; Grupo de Trabajo de las Guías de Actuación. Giraldo P, et al. Med Clin (Barc). 2011 Sep;137 Suppl 1:55-60. doi: 10.1016/S0025-7753(11)70019-7. Med Clin (Barc). 2011. PMID: 22230128 Spanish.

7

Mapping the genetic and clinical characteristics of Gaucher disease in the Iberian Peninsula.

Giraldo P, Alfonso P, Irún P, Gort L, Chabás A, Vilageliu L, Grinberg D, Sá Miranda CM, Pocovi M. Giraldo P, et al. Orphanet J Rare Dis. 2012 Mar 19;7:17. doi: 10.1186/1750-1172-7-17. Orphanet J Rare Dis. 2012. PMID: 22429443 Free PMC article.

8

RIT with Y90-Ibritumomab Tiuxetan in Follicular Non-Hodgkin Lymphoma: Evaluation of Recent Outcomes in a Single Institution.

Andrade Campos MM, Montes Limón AE, Grasa JM, Lievano P, Baringo T, Giraldo P. Andrade Campos MM, et al. Among authors: giraldo p. J Oncol. 2012;2012:412742. doi: 10.1155/2012/412742. Epub 2012 Sep 25. J Oncol. 2012. PMID: 23049552 Free PMC article.

9

Long-term efficacy of (90)Y ibritumomab tiuxetan therapy in follicular non-Hodgkin lymphoma and health-related quality of life.

Andrade-Campos MM, Montes-Limón AE, Soro-Alcubierre G, Grasa JM, Lopez-Gómez L, Baringo T, Giraldo P. Andrade-Campos MM, et al. Among authors: giraldo p. Ann Hematol. 2014 Dec;93(12):1985-92. doi: 10.1007/s00277-014-2145-6. Epub 2014 Jul 3. Ann Hematol. 2014. PMID: 24985089

10

Iron homeostasis and infIammatory biomarker analysis in patients with type 1 Gaucher disease.

Medrano-Engay B, Irun P, Gervas-Arruga J, Andrade-Campos M, Andreu V, Alfonso P, Pocovi M, Giraldo P. Medrano-Engay B, et al. Among authors: giraldo p. Blood Cells Mol Dis. 2014 Dec;53(4):171-5. doi: 10.1016/j.bcmd.2014.07.007. Epub 2014 Aug 18. Blood Cells Mol Dis. 2014. PMID: 25153906

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

394 results

Search Page